Cerebroprotein Hydrolysate is a biologically derived peptide complex produced through controlled enzymatic hydrolysis of porcine brain proteins. It contains a mixture of low-molecular-weight peptides and free amino acids rather than one chemically defined molecule. Because of this complex biological composition, its identity and quality are generally established through product-specific analytical specifications rather than a single molecular formula or molecular weight.
MEDIOCON INC supplies Cerebroprotein Hydrolysate Tablets for qualified pharmaceutical requirements. In the Indian market, 90 mg Cerebroprotein Hydrolysate tablets are commercially available in oral tablet form. Current pharmaceutical listings identify Cerebroprotein Hydrolysate 90 mg as the active ingredient in several tablet products.
Cerebroprotein Hydrolysate is classified as a neurotrophic peptide complex and is used in pharmaceutical products intended for neurological indications. Current Indian medicine references list uses including stroke, head injury and Alzheimer's disease. Because this is a medicinal product, use and dosing should be determined by a qualified healthcare professional and according to the approved product information.
The tablet dosage form provides a convenient oral presentation of Cerebroprotein Hydrolysate. Commercial examples include 90 mg tablets, with some products supplied in 10-tablet strips or 10 × 10 tablet packs. Product specifications, excipients, tablet weight, dissolution/disintegration requirements and packaging configuration can differ between manufacturers.
MEDIOCON INC can supply Cerebroprotein Hydrolysate Tablets according to the required strength, formulation, packaging and applicable pharmaceutical quality standards. Customers can request the relevant Certificate of Analysis (COA), specification sheet, TDS, SDS, manufacturing documentation and other applicable quality documents. Final specifications should always be confirmed against the actual MEDIOCON batch and approved product dossier.
CAS note: 12656-61-0 is reported for Cerebroprotein Hydrolysate/Cerebrolysin in some current chemical/reference databases. However, because the material is a complex biological peptide mixture, CAS, formula and molecular weight should ultimately be verified against the supplier's regulatory documentation rather than treated like a single defined molecule.
A complex mixture of low-molecular-weight peptides and amino acids obtained through controlled enzymatic hydrolysis of porcine brain proteins.
90 mg per tablet is a commercially marketed tablet strength in India.
Oral tablet.
Neurotrophic peptide / CNS pharmaceutical.
Porcine brain-derived protein hydrolysate.
Mediocon Inc is a GMP-certified API manufacturer and bulk pharmaceutical ingredient supplier based in Aurangabad, Maharashtra, India. We specialise in supplying Cerebroprotein Hydrolysate Tablets Manufacturer & Supplier in India | MEDIOCON INC (CAS 12656-61-0*) and over 1,000 other Active Pharmaceutical Ingredients, excipients, herbal extracts, and nutraceutical ingredients to pharmaceutical manufacturers worldwide.
Our Cerebroprotein Hydrolysate Tablets Manufacturer & Supplier in India | MEDIOCON INC is manufactured under strict quality management protocols compliant with WHO-GMP, ISO 9001:2015, and major pharmacopoeial standards (IP, BP, USP, EP). Every batch undergoes full analytical testing before release with a Certificate of Analysis.
Export Markets
Quality & Compliance